Zoloft Oral Solution Generic Name & Formulations
Legal Class
General Description
Pharmacological Class
See Also
How Supplied
Tabs 25mg—30; 50mg, 100mg—30, 100; Soln—60mL (w. dropper)
Manufacturer
Generic Availability
Mechanism of Action
Zoloft Oral Solution Indications
Indications
Zoloft Oral Solution Dosage and Administration
Adult
Children
Zoloft Oral Solution Contraindications
Contraindications
Zoloft Oral Solution Boxed Warnings
Boxed Warning
Zoloft Oral Solution Warnings/Precautions
Warnings/Precautions
Increased risk of suicidal thinking and behavior in children, adolescents, and young adults; monitor for clinical worsening or unusual changes. Screen for bipolar disorder, mania, or hypomania. Monitor for serotonin syndrome; discontinue if occurs. Seizure disorders. QT prolongation. Risk for bleeding events. Angle-closure glaucoma; avoid. Monitor weight and growth in children. Discontinue if symptomatic hyponatremia occurs. Volume-depleted. Sexual dysfunction. Hepatic impairment. Write ℞ for smallest practical amount. Avoid abrupt cessation. Reevaluate periodically. Elderly. Labor & delivery. Pregnancy (during 3rd trimester; see full labeling for effects on neonates). Nursing mothers.
Zoloft Oral Solution Pharmacokinetics
Absorption
Mean peak plasma concentrations (Cmax) of sertraline occurred between 4.5–8.4 hours post-dosing.
Distribution
Plasma protein bound: 98%.
Elimination
Renal, fecal. Half-life: ~26 hours.
Zoloft Oral Solution Interactions
Interactions
See Contraindications. Increased risk of serotonin syndrome with other serotonergic drugs (eg, other SSRIs, SNRIs, triptans, TCAs, fentanyl, lithium, tramadol, meperidine, methadone, tryptophan, buspirone, St. John's Wort) or with drugs that impair serotonin metabolism (eg, MAOIs, linezolid, IV methylene blue). Avoid alcohol. May potentiate or be potentiated by protein bound drugs (eg, warfarin); reduce dose if needed. May potentiate CYP2D6 substrates (eg, propafenone, flecainide, atomoxetine, desipramine, dextromethorphan, metoprolol, nebivolol, perphenazine, thioridazine, tolterodine, venlafaxine); reduce dose of these. Increased risk of bleeding with concomitant aspirin, NSAIDs, clopidogrel, heparin, warfarin, and others that affect coagulation. Avoid concomitant drugs known to prolong the QT interval (eg, ziprasidone, iloperidone, chlorpromazine, mesoridazine, droperidol, erythromycin, gatifloxacin, moxifloxacin, sparfloxacin, Class IA & III antiarrhythmics, pentamidine, methadone, mefloquine, and others). Monitor phenytoin, warfarin. May cause false (+) urine test for benzodiazepines.
Zoloft Oral Solution Adverse Reactions
Adverse Reactions
Zoloft Oral Solution Clinical Trials
See Literature
Zoloft Oral Solution Note
Not Applicable
Zoloft Oral Solution Patient Counseling
See Literature
Zoloft Oral Solution Generic Name & Formulations
Legal Class
General Description
Pharmacological Class
See Also
How Supplied
Tabs 25mg—30; 50mg, 100mg—30, 100; Soln—60mL (w. dropper)
Manufacturer
Generic Availability
Mechanism of Action
Zoloft Oral Solution Indications
Indications
Zoloft Oral Solution Dosage and Administration
Adult
Children
Zoloft Oral Solution Contraindications
Contraindications
Zoloft Oral Solution Boxed Warnings
Boxed Warning
Zoloft Oral Solution Warnings/Precautions
Warnings/Precautions
Increased risk of suicidal thinking and behavior in children, adolescents, and young adults; monitor for clinical worsening or unusual changes. Screen for bipolar disorder, mania, or hypomania. Monitor for serotonin syndrome; discontinue if occurs. Seizure disorders. QT prolongation. Risk for bleeding events. Angle-closure glaucoma; avoid. Monitor weight and growth in children. Discontinue if symptomatic hyponatremia occurs. Volume-depleted. Sexual dysfunction. Hepatic impairment. Write ℞ for smallest practical amount. Avoid abrupt cessation. Reevaluate periodically. Elderly. Labor & delivery. Pregnancy (during 3rd trimester; see full labeling for effects on neonates). Nursing mothers.
Zoloft Oral Solution Pharmacokinetics
Absorption
Mean peak plasma concentrations (Cmax) of sertraline occurred between 4.5–8.4 hours post-dosing.
Distribution
Plasma protein bound: 98%.
Elimination
Renal, fecal. Half-life: ~26 hours.
Zoloft Oral Solution Interactions
Interactions
See Contraindications. Increased risk of serotonin syndrome with other serotonergic drugs (eg, other SSRIs, SNRIs, triptans, TCAs, fentanyl, lithium, tramadol, meperidine, methadone, tryptophan, buspirone, St. John's Wort) or with drugs that impair serotonin metabolism (eg, MAOIs, linezolid, IV methylene blue). Avoid alcohol. May potentiate or be potentiated by protein bound drugs (eg, warfarin); reduce dose if needed. May potentiate CYP2D6 substrates (eg, propafenone, flecainide, atomoxetine, desipramine, dextromethorphan, metoprolol, nebivolol, perphenazine, thioridazine, tolterodine, venlafaxine); reduce dose of these. Increased risk of bleeding with concomitant aspirin, NSAIDs, clopidogrel, heparin, warfarin, and others that affect coagulation. Avoid concomitant drugs known to prolong the QT interval (eg, ziprasidone, iloperidone, chlorpromazine, mesoridazine, droperidol, erythromycin, gatifloxacin, moxifloxacin, sparfloxacin, Class IA & III antiarrhythmics, pentamidine, methadone, mefloquine, and others). Monitor phenytoin, warfarin. May cause false (+) urine test for benzodiazepines.
Zoloft Oral Solution Adverse Reactions
Adverse Reactions
Zoloft Oral Solution Clinical Trials
See Literature
Zoloft Oral Solution Note
Not Applicable
Zoloft Oral Solution Patient Counseling
See Literature